Lancet

Published by: Elsevier Science, Inc.  

People

  1. Kingham
    Kingham
  2. Robson
    Robson
  3. Offit
    Offit
  4. Bach
    Bach
  5. Breitbart
    Breitbart
  6. Carlsson
    Carlsson
  7. Horwitz
    Horwitz
  8. Sklar
    Sklar
  9. Berger
    Berger
  10. Drullinsky
    Drullinsky

Groups

  1. Population Sciences Research Program (21)
  2. Department of Medicine (7)
  3. Survivorship Research (7)
  4. Epidemiology and Biostatistics (6)
  5. Surgery (6)
  6. Breast Medicine Service (5)
  7. Health Outcomes Research Group (5)
  8. Solid Tumor Oncology Division (5)
  9. Center for Pancreatic Cancer Research (4)
  10. GSK Faculty (4)
Search Within
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (1)
Groups
  1. Population Sciences Research Program (21)
  2. Department of Medicine (7)
  3. Survivorship Research (7)
  4. Epidemiology and Biostatistics (6)
  5. Surgery (6)
  6. Breast Medicine Service (5)

More Groups

People
  1. Mark Robson (4)
  2. T Peter Kingham (4)
  3. Kenneth Offit (3)
  4. Charles Sklar (2)
  5. Peter Bach (2)
  6. Sigrid Carlsson (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (1)
  4. 2019 (1)
  5. 2017 (1)
  6. 2015 (1)

More Years

Publishers
  1. Elsevier Science, Inc. (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Blood-based tests for multicancer early detection (PATHFINDER): A prospective cohort study
    Journal Article

    Schrag, D.; Beer, T. M.; McDonnell, C. H. 3rd; Nadauld, L.; Dilaveri, C. A.; Reid, R.; Marinac, C. R.; Chung, K. C.; Lopatin, M.; Fung, E. T.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • Global variation in postoperative mortality and complications after cancer surgery: A multicentre, prospective cohort study in 82 countries
    Journal Article

    GlobalSurg Collaborative and National Institute for Health Research Global Health Research Unit on Global Surgery
    Lancet (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): A global, double-blind, randomised, phase 3 trial
    Journal Article

    Horwitz, S.; O'Connor, O. A.; Pro, B.; Illidge, T.; Fanale, M.; Advani, R.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domingo-Domenech, E.; more...
    Lancet (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): An international, open-label, randomised, phase 3, multicentre trial
    Journal Article

    Prince, H. M.; Kim, Y. H.; Horwitz, S. M.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; Wolter, P.; Sanches, J. A.; Ortiz-Romero, P. L.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Rectal bleeding and endoscopy need in Sierra Leone: Results of a nationwide, community-based survey
    Meeting Abstract

    Stewart, B. T.; Groen, R. S.; Kamara, T. B.; Kwon, S.; Kingham, T. P.; Kushner, A. L.
    Lancet (2015)

    Fulltext@MSK | Save
  • Prostate cancer screening in Europe - Authors' reply
    Journal Article

    Schröder, F.; Hugosson, J.; Carlsson, S.; Moss, S.; Roobol, M.; Auvinen, A.
    Lancet (2014)

    Fulltext@MSK | Save
  • Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
    Journal Article

    Schröder, F. H.; Hugosson, J.; Roobol, M. J.; Tammela, T. L. J.; Zappa, M.; Nelen, V.; Kwiatkowski, M.; Lujan, M.; Määttänen, L.; Lilja, H.; more...
    Lancet (2014)

    Fulltext@MSK | Save
  • Childhood cancer, endocrine disorders, and cohort studies
    Journal Article

    Oeffinger, K. C.; Sklar, C. A.
    Lancet (2014)

    Fulltext@MSK | Save
  • Increasing value and reducing waste: Addressing inaccessible research
    Journal Article

    Chan, A. W.; Song, F.; Vickers, A.; Jefferson, T.; Dickersin, K.; Gøtzsche, P. C.; Krumholz, H. M.; Ghersi, D.; Van Der Worp, H. B.
    Lancet (2014)

    Fulltext@MSK | Save

    • Lancet – authorized name for:

    Name ISSN / ISBN Publisher
    Lancet 0140-6736 Elsevier Science, Inc.
    Lancet 01406736 Unknown
    Lancet 0140-6736 Elsevier Science, Inc.
    Lancet 0140-6736 The Lancet Publishing Group
    Lancet 0140-6736 Elsevier Science, Inc.
    Lancet 0099-5355 The Lancet Publishing Group
    Lancet 1083-7159 Unknown
    Lancet 0099-5355 Unknown
    Lancet 0140-6736 Unknown
    Lancet 1474547X Unknown
    Lancet 1474-547X Elsevier Science, Inc.
    Lancet 0140-6736 Elsevier Science, Inc.
    Lancet 0140-6736 Elsevier Science, Inc.
    Lancet (North American Edition) 0140-6736 Unknown
    The Lancet 01406736 Elsevier Inc.
    The Lancet 0140-6736 Elsevier Science, Inc.
    The Lancet 01406736 1995
    The Lancet 1474547X Unknown
    The Lancet 01406736 Unknown
    The Lancet 01406736 1993
    The Lancet 0140-6736 Lancet United Kingdom
    The Lancet 01406736 1994
    The Lancet 01406736 Unknown
    The Lancet 0140-6736 Elsevier Inc.